← 返回首页
美国 · 股市与财经 · Yahoo Finance

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

来源:Yahoo Finance · 美国 10 小时前

Data presentations build on the July 2026 FDA approval and U.S. launch of Furoscix ReadyFlow, the first and only autoinjector delivering IV-equivalent diuretic therapy for heart…

在 Yahoo Finance 阅读全文 登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (finance.yahoo.com)

推荐阅读